rdca-dap - value of integrated data and analytics in rare disease drug development
Published 3 years ago • 314 plays • Length 48:02Download video MP4
Download video MP3
Similar videos
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
57:06
the role of integrated datasets in addressing rare diseases research challenges
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development
-
1:00:52
rdca-dap: exploring/visualizing data in rdca-dap to identify data of interest for advanced analysis
-
12:25
using rdca-dap: searchability and data analytics
-
5:09
how are pharmaceutical companies using artificial intelligence?
-
30:46
ai in clinical decision support: roadblocks & opportunities | niki athanasiadou
-
10:08
disease prediction system using machine learning projects
-
4:12
why are high-quality standardized databases so critical for drug development?
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
45:31
derisking rare disease drug development and measuring impact and outcomes with andrew lo
-
8:22
why is this platform useful and relevant to the prader-willi community?
-
9:45
rdca-dap responsive curation levels
-
20:41
2022 rdca-dap workshop: case study 1, transplant therapeutics consortium (ttc)
-
57:08
industry perspective on drug development in rare diseases
-
46:37
clinical trial simulation tools advancing treatments in rare disease
-
8:10
do you think the community will work together to share data, or do you anticipate resistance?
-
57:04
rdca-dap: interpretation of novel biomarkers in related diseases through data interoperability
-
22:33
2021 pkd regulatory summit: data sharing – value proposition for the future of rare disease r&d